Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects
Condition: Pharmacokinetics Interventions: Drug: PRA; Drug: SCY-078 plus PRA Sponsors: Scynexis, Inc.; Clinical Network Services (CNS) Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2019 Category: Research Source Type: clinical trials